• 54
  • 8
  • Favorite

Acumen Pharmaceuticals Pursues $125 Million IPO

seekingalpha2021-07-01

Summary Acumen Pharmaceuticals has filed proposed terms for a $125 million IPO. The firm is developing a treatment for Alzheimer's Disease. ABOS is researching a notoriously difficult area, so the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment8

  • DarylBin
    ·2021-07-01
    Good
    Reply
    Report
  • Geminifx
    ·2021-07-01
    Ok
    Reply
    Report
  • Shishir
    ·2021-07-01
    Yes.
    Reply
    Report
  • Shishir
    ·2021-07-01
    Good dY
    Reply
    Report
  • Amazingday
    ·2021-07-01
    Good day
    Reply
    Report
  • Amazingday
    ·2021-07-01
    Good day
    Reply
    Report
  • IZLIN
    ·2021-07-01
    Reply
    Report
  • Huilun
    ·2021-07-01
    Like this pls thank you
    Reply
    Report
    Fold Replies
    • Leongny
      Done please do the same
      2021-07-01
      Reply
      Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial